Literature DB >> 10972571

Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?

D I Velligan1, C C Bow-Thomas, R K Mahurin, A L Miller, L C Halgunseth.   

Abstract

We examined whether specific neurocognitive deficits predicted specific domains of community outcome in 40 schizophrenic patients. Neuropsychological assessments were conducted before hospital discharge, and measures of functional outcome were obtained 1 to 3.5 years later. A priori hypotheses were generated based upon a recent review by Green (Green MF [1996] What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153(3):321-330). As hypothesized, verbal memory predicted all measures of community outcome, vigilance predicted social outcomes, and executive functioning predicted work and activities of daily living (ADLs). However, in addition to the predicted relationships, many other associations were found between neuropsychological test scores and adaptive function. Furthermore, both cognitive and functional measures were intercorrelated. If deficits in adaptive functioning are neurocognitively multi-determined, utilizing compensatory strategies to bypass multiple areas of cognitive impairment may be more efficient than cognitive remediation in improving community outcomes.

Entities:  

Mesh:

Year:  2000        PMID: 10972571     DOI: 10.1097/00005053-200008000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  46 in total

1.  Executive control in chronic schizophrenia: A perspective from manual stimulus-response compatibility task performance.

Authors:  Simone D Behrwind; Manuel Dafotakis; Sarah Halfter; Kerstin Hobusch; Mark Berthold-Losleben; Edna C Cieslik; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

Review 2.  Profiles of neuropsychologic function in schizophrenia.

Authors:  J Daniel Ragland
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 3.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 4.  [Effectiveness of Integrated Psychological Therapy for schizophrenia patients. A meta-analysis including 28 independent studies].

Authors:  D R Müller; V Roder; H D Brenner
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

5.  Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Authors:  Dwight Dickinson; James M Gold
Journal:  Schizophr Bull       Date:  2007-08-16       Impact factor: 9.306

6.  A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.

Authors:  Dawn I Velligan; David Roberts; Jim Mintz; Natalie Maples; Xueying Li; Elisa Medellin; Matt Brown
Journal:  Schizophr Res       Date:  2015-05-01       Impact factor: 4.939

Review 7.  Cognitive remediation in schizophrenia-The view from India.

Authors:  Smita N Deshpande; Triptish Bhatia; E Mohandas; Vishwajit L Nimgaonkar
Journal:  Asian J Psychiatr       Date:  2016-06-24

8.  Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Early Interv Psychiatry       Date:  2016-09-15       Impact factor: 2.732

9.  Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status.

Authors:  Marte Tandberg; Kjetil Sundet; Ole A Andreassen; Ingrid Melle; Torill Ueland
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-13       Impact factor: 4.328

10.  Neuropsychological impairments predict the clinical course in schizophrenia.

Authors:  Wolfgang Wölwer; Jürgen Brinkmeyer; Mathias Riesbeck; Lena Freimüller; Ansgar Klimke; Michael Wagner; Hans-Jürgen Möller; Stefan Klingberg; Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.